4.7 Article

Influenza A/Subtype and B/Lineage Effectiveness Estimates for the 2011-2012 Trivalent Vaccine: Cross-Season and Cross-Lineage Protection With Unchanged Vaccine

Related references

Note: Only part of the references are listed.
Letter Immunology

Stratified Estimates of Influenza Vaccine Effectiveness by Prior Vaccination: Caution Required

Sheena G. Sullivan et al.

CLINICAL INFECTIOUS DISEASES (2013)

Letter Immunology

Understanding Suboptimal Influenza Vaccine Effectiveness Within the Agent, Host, and Environment Paradigm

Danuta M. Skowronski et al.

CLINICAL INFECTIOUS DISEASES (2013)

Article Immunology

Influenza Vaccine Effectiveness in the Community and the Household

Suzanne E. Ohmit et al.

CLINICAL INFECTIOUS DISEASES (2013)

Review Infectious Diseases

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis

Michael T. Osterholm et al.

LANCET INFECTIOUS DISEASES (2012)

Article Immunology

Kinetics of the Antibody Response to Seasonal Influenza Vaccination Among the Elderly

Uraiwan Kositanont et al.

VIRAL IMMUNOLOGY (2012)

Article Biotechnology & Applied Microbiology

Persistence of influenza vaccine-induced antibody in lung transplant patients and healthy individuals beyond the season

Jill J. Severson et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)

Review Infectious Diseases

Serologic assays for influenza surveillance, diagnosis and vaccine evaluation

Jacqueline M. Katz et al.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)

Article Immunology

Rapid decline of influenza vaccine-induced antibody in the elderly: Is it real, or is it relevant?

Danuta M. Skowronski et al.

JOURNAL OF INFECTIOUS DISEASES (2008)

Article Public, Environmental & Occupational Health

Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness

Evan W. Orenstein et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2007)

Article Virology

Recent changes among human influenza viruses

YP Lin et al.

VIRUS RESEARCH (2004)